**Inhibition of Glycogenolysis and Gluconeogenesis**

**Core Concept**
Glycogenolysis and gluconeogenesis are two metabolic pathways that provide glucose to the body during fasting or low-glucose states. Glycogenolysis is the breakdown of glycogen to glucose, while gluconeogenesis is the synthesis of glucose from non-carbohydrate sources.

**Why the Correct Answer is Right**
The correct answer is a type of hormone that inhibits glycogenolysis and gluconeogenesis. Insulin, secreted by the pancreas, has a key role in regulating these pathways. When insulin binds to its receptor on the surface of liver cells, it activates a cascade of intracellular signaling pathways that inhibit glycogenolysis (via phosphorylation of glycogen synthase kinase-3) and gluconeogenesis (via inhibition of phosphoenolpyruvate carboxykinase). This results in decreased glucose production and increased glucose uptake in the body.

**Why Each Wrong Option is Incorrect**
* **Option A:** Glucagon has the opposite effect of insulin, stimulating glycogenolysis and gluconeogenesis to increase glucose production in the body.
* **Option B:** Aldosterone is a hormone involved in electrolyte balance and blood pressure regulation, and has no direct effect on glycogenolysis or gluconeogenesis.
* **Option D:** Growth hormone has various effects on metabolism, including anabolic effects, but is not primarily involved in inhibiting glycogenolysis or gluconeogenesis.

**Clinical Pearl / High-Yield Fact**
Insulin is a critical hormone in glucose homeostasis, and its deficiency or resistance can lead to hyperglycemia and diabetes mellitus.

**Correct Answer:** C. Insulin.